Integra Lifesciences Holdings (IART) Change in Cash (2009 - 2026)

Integra Lifesciences Holdings has disclosed Change in Cash across 18 years of filings, most recently posting -$22.4 million for Q2 2026.

• In Q2 2026, Change in Cash fell 5.68% year-over-year to -$22.4 million; the TTM figure through Jun 2026 stood at -$3.5 million (down 230.66% YoY), while the FY2025 annual figure was -$11.3 million, up 62.28% from the prior year.
• Change in Cash came in at -$22.4 million for Q2 2026 at Integra Lifesciences Holdings, down from $1.8 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $315.5 million in Q1 2024 to a low of -$376.7 million in Q2 2024.
• Average Change in Cash over 5 years is -$16.6 million, with a median of $841000.0 recorded in 2024.
• Year-over-year, Change in Cash plunged 20739.45% in 2024 and surged 18165.82% in 2025.
• Over 5 years, Change in Cash stood at -$55.3 million in 2022, then soared by 104.83% to $2.7 million in 2023, then jumped by 1069.21% to $31.2 million in 2024, then sank by 90.83% to $2.9 million in 2025, then slumped by 882.46% to -$22.4 million in 2026.
• Per Business Quant data, the three most recent Change in Cash figures were -$22.4 million in Q2 2026, $1.8 million in Q1 2026, and $2.9 million in Q4 2025.